Back to 
Berkshire Hathaway Inc.
Berkshire Hathaway Inc.
TEVA
Showing 0 of 13 quarters
Position history for Berkshire Hathaway Inc.'s holdings in Teva Pharmaceutical Industries Limited
No. Berkshire Hathaway exited its TEVA (Teva Pharmaceutical Industries) position in Q4 2021. Its Q3 2021 13F listed 42,789,295 shares worth $416.8M. Berkshire Hathaway already held TEVA in its Q4 2018 13F, the earliest on record, and held it in 12 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.